stars 1 stars 2 stars 3

CO.DON GmbH, a ReLive Biotechnologies company, is a biopharmaceutical company and manufacturer of cell transplants. With more than 30 years of experience in tissue engineering, we focus on regenerative, joint-preserving cell therapies for the treatment of cartilage defects using only the patient’s own cells. Our mission and passion: We want patients to continue their active lives with the help of our therapies. Our headquarters and manufacturing site is based in Germany. In addition, we operate in the following countries via subsidiaries or distribution partners: Austria, the United Kingdom and the Netherlands. In line with the company's vision, CO.DON is actively working to make its EU-wide authorized pharmaceutical product available to more patients in other European countries.

CO.DON GmbH Questions

The CO.DON GmbH annual revenue was $9.8 million in 2026.

Giulietta Roël is the Executive Director Manufacturing of CO.DON GmbH.

36 people are employed at CO.DON GmbH.

The NAICS codes for CO.DON GmbH are [54171, 541711, 5417, 54, 339, 541, 33].

The SIC codes for CO.DON GmbH are [38, 384].

G2 Leader Summer 2026 G2 Best Est ROI Mid-Market Summer 2026 G2 Easiest Admin Mid-Market Summer 2026 G2 Most Implementable Summer 2026 G2 Best Results Mid-Market Summer 2026 G2 Lead Capture Mid-Market Summer 2026 Inc Fastest Growing Private Companies 2026 Inc Best Workplace 2026
g2crowd
G2Crowd Trusted
chromestore
300K+ Plugin Users